Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam D Cohen

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Leukemia|March 30, 2022
CAR T cell therapy for multiple myeloma: What have we learned?Sandra Susanibar Adaniya, Edward A Stadtmauer, Adam D Cohen
The New England Journal of Medicine|January 5, 2008
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosisRaymond L Comenzo, Richard M Steingart, Adam D Cohen
Neurology|September 5, 2024
Clinical Reasoning: A 49-Year-Old Man With Progressive Numbness, Gait Instability, and TremorsFelipe J S Jones, Adam D Cohen, Chafic Karam
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
Anti-GITR antibodies--potential clinical applications for tumor immunotherapyDavid A Schaer, Adam D Cohen, Jedd D Wolchok
Muscle & Nerve|May 31, 2024
Paraproteinemic neuropathiesRebecca Traub, Taha Qarni, Adam D Cohen, et al.
Journal of Consulting and Clinical Psychology|October 13, 2006
Writing about the benefits of an interpersonal transgression facilitates forgivenessMichael E McCullough, Lindsey M Root, Adam D Cohen
Frontiers in Immunology|January 7, 2014
Combination immune therapies to enhance anti-tumor responses by NK cellsAshley Mentlik James, Adam D Cohen, Kerry S Campbell
American Journal of Hematology|February 8, 2019
Chimeric antigen receptor T cell immunotherapy for multiple myeloma: A review of current data and potential clinical applicationsSandra P Susanibar Adaniya, Adam D Cohen, Alfred L Garfall
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Hematologic Malignancies: Plasma Cell DisordersMadhav V Dhodapkar, Ivan Borrello, Adam D Cohen, et al.
Future Oncology (London, England)|July 5, 2023
Plain language summary of the CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myelomaJesus G Berdeja, Adam D Cohen, Thomas Martin, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Leukemia|March 30, 2022
CAR T cell therapy for multiple myeloma: What have we learned?Sandra Susanibar Adaniya, Edward A Stadtmauer, Adam D Cohen
The New England Journal of Medicine|January 5, 2008
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosisRaymond L Comenzo, Richard M Steingart, Adam D Cohen
Neurology|September 5, 2024
Clinical Reasoning: A 49-Year-Old Man With Progressive Numbness, Gait Instability, and TremorsFelipe J S Jones, Adam D Cohen, Chafic Karam
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
Anti-GITR antibodies--potential clinical applications for tumor immunotherapyDavid A Schaer, Adam D Cohen, Jedd D Wolchok
Muscle & Nerve|May 31, 2024
Paraproteinemic neuropathiesRebecca Traub, Taha Qarni, Adam D Cohen, et al.
Journal of Consulting and Clinical Psychology|October 13, 2006
Writing about the benefits of an interpersonal transgression facilitates forgivenessMichael E McCullough, Lindsey M Root, Adam D Cohen
Frontiers in Immunology|January 7, 2014
Combination immune therapies to enhance anti-tumor responses by NK cellsAshley Mentlik James, Adam D Cohen, Kerry S Campbell
American Journal of Hematology|February 8, 2019
Chimeric antigen receptor T cell immunotherapy for multiple myeloma: A review of current data and potential clinical applicationsSandra P Susanibar Adaniya, Adam D Cohen, Alfred L Garfall
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Hematologic Malignancies: Plasma Cell DisordersMadhav V Dhodapkar, Ivan Borrello, Adam D Cohen, et al.
Future Oncology (London, England)|July 5, 2023
Plain language summary of the CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myelomaJesus G Berdeja, Adam D Cohen, Thomas Martin, et al.
Pageof 11